Equillium share price logo

Equillium

NASDAQ: EQ

$1.29

-0.03

(-2.27%)

as on

Equillium Stock Performance

as on November 14, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $1.27
    $1.34
    downward going graph

    1.55%

    Downside

    3.88%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.76
    $3.54
    downward going graph

    41.38%

    Downside

    174.42%

    Upside

    downward going graph

Equillium share price movements today

Previous Close
$1.32
Open
$1.34
Volume
572.5K
Market Cap
$111.3M
Day's Low - High
$1.27 - $1.34
52 Week Low - High
$0.76 - $3.54

Equillium Historical Returns

1 Month Return
0 %
3 Month Return
-34.33 %
1 Year Return
+ 57.14 %
3 Year Return
+ 164 %
5 Year Return
-76.22 %

Equillium Stock Fundamentals & Key Indicators

Check Equillium market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$111.3M

EPS (TTM)

-0.2563

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.54

Industry PE ratio

-2.60

PEG Ratio

-0.09

EBITDA

-18.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-41.15%

Equillium vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Equillium with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$111.3M-76.22%-5.540.00%0.00%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$48.0BNA68.5088.39%0.00%
StrongBuy$138.7B189.72%34.9385.57%0.00%
Buy$94.7B50.70%20.4385.77%0.39%

Stock Returns calculator for Equillium Stock including INR - Dollar returns

The Equillium stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Equillium investment value today

Current value as on today

₹1,62,931

Returns

₹62,931

(+62.93%)

Returns from Equillium Stock

₹53,571 (+53.57%)

Dollar Impact

₹9,359 (+9.36%)

Analyst Recommendation on Equillium Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Equillium. Average target price of $8.56

Equillium Share Price Target

Get share price movements and forecasts by analysts on Equillium.

What analysts predicted

84.93%UPSIDE

Target Price

$8.56

Current Price

$1.29

Analyzed by

4 Analysts

High

$20

Target

$8.56

Low

$6

Equillium target price $8.56, a slight upside of 84.93% compared to current price of $1.29. According to 4 analysts rating.

Indian Investors' Interest in Equillium Stock

Search interest for Equillium Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Equillium Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
10
13
12
4
-
-
-
-
-
-
Gross Profit
10
13
12
4
-
0
-
0
0
-
Operating Income
-2
0
0
-4
-8
-6
-4
-3
-5
-5
EBITDA
-2
0
0
-5
-8
-5
-4
-3
-5
-5
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
0
0
-5
-8
-5
-4
-3
-5
-4
Income Tax Expense
-
-
-
0
-
-
-
-
-
-
Net Income
-2
0
0
-5
-8
-5
-4
-3
-5
-4
Net Profit Margin
99.70%
100.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Equillium Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
15
36
41
-
Gross Profit
0
0
0
0
0
15
36
41
0
Operating Income
-1
-8
-26
-29
-37
-62
-14
-8
-23
EBITDA
-1
-10
-25
-28
-37
-61
-12
-7
-22
Interest Expense
0
2
0
1
1
1
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-13
-25
-29
-39
-62
-12
-7
-22
Income Tax Expense
0
0
-
-
-
-
0
0
-
Net Income
-2
-13
-25
-29
-38
-62
-13
-8
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
0.00%

Equillium Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
0
0
-5
-8
-5
-4
-3
-5
-4
Operating Cash Flow
-8
0
-7
-3
-8
-3
-8
-3
-4
-4
Investing Cash Flow
-2
-1
12
5
4
-
-
0
0
0
Financing Cash Flow
-
0
-
0
0
0
30
0
35
0
Change in Cash
-11
0
4
2
-3
-3
21
-2
31
-4

Equillium Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-13
-25
-29
-39
-62
-13
-8
-22
Operating Cash Flow
0
-7
-22
-24
-32
-8
-21
-19
-22
Investing Cash Flow
0
-37
-2
-18
27
18
-4
13
4
Financing Cash Flow
7
66
9
53
31
-1
-9
0
30
Change in Cash
7
21
-15
10
26
8
-35
-5
12

Global Institutional Holdings in Equillium

Check out the Institutions with significant holdings in Equillium.

Funds
Holdings
Daniel Bradbury
5.85%
Bruce D. Steel
5.85%
Michael Rockefeller
5.52%
Peter Kolchinsky
4.88%
Vanguard
3.10%

Equillium News & Key Events

  • img

    Today's Timeline - 26 October

    Mon, 06:50 PM

    -

    Equillium doses first subject in Phase 1 trial of EQ504, targeting serious inflammatory diseases.

    Tue, 02:58 AM

    -

    Equillium reports trial milestone, extends cash runway to support operations into 2029.

Insights on Equillium

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 229.5% return, outperforming this stock by 65.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 826.9% return, outperforming this stock by 769.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EQ stock has moved down by -12.6%

About Equillium

Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.
OrganisationEquillium
Headquarters2223 Avenida De La Playa, La Jolla, CA, 92037, US
IndustryBiotechnology
CEOBruce D. Steel

Key Management of Equillium

Name

Title

Ms. Penny Tom CPA

Senior VP of Finance & Principal Accounting Officer

Mr. Michael Moore

Vice President of Investor Relations & Corporate Communications

Mr. Bruce Steel

Co-Founder, CEO & Director

Dr. Stephen Connelly Ph.D.

Chief Scientific Officer & President

Ms. Christine Zedelmayer M.B.A., P.M.P.

Senior VP & COO

FAQs

What is Equillium share price today?

Equillium share price today is $1.29 as on at the close of the market. Equillium share today touched a day high of $1.34 and a low of $1.27.

What is the 52 week high and 52 week low for Equillium share?

Equillium share touched a 52 week high of $3.54 on and a 52 week low of $0.76 on . Equillium stock price today i.e. is closed at $1.29,which is 63.56% down from its 52 week high and 70.59% up from its 52 week low.

What is Equillium's market capitalisation today?

Equillium market capitalisation is $0.00T as on .

How to invest in Equillium Stock (EQ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Equillium on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Equillium Stock (EQ) from India?

Indian investors can start investing in Equillium (EQ) shares with as little as ₹94.2300033569336 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.30 in Equillium stock (as per the Rupee-Dollar exchange rate as on ). Based on Equillium share’s latest price of $1.29 as on November 14, 2026 at 2:29 am IST, you will get 7.7519 shares of Equillium. Learn more about fractional shares .

What are the returns that Equillium has given to Indian investors in the last 5 years?

Equillium stock has given -76.22% share price returns and 26.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?